Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Is the Current and Projected Market Size of the Chikungunya Market Through 2034?
In recent times, the market size of chikungunya has seen substantial growth. It is predicted to expand from $0.59 billion in 2024 to $0.65 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.8%. The growth in the preceding period is due to several factors including an increase in healthcare expenditures per person, a rise in the occurrence of new and recurring infectious diseases, growth in disposable income, changes in climate, and heightened awareness about mosquito-borne diseases.
The market size for chikungunya is projected to experience substantial growth in the coming years, reaching $0.93 billion by 2029 with a compound annual growth rate (CAGR) of 9.4%. This predicted growth during the forecast period is mainly due to numerous factors including an increase in global clinical trials, a surging elderly population, an escalating demand for immunization, and growing initiatives by both government and non-government bodies. Moreover, increased government investments and positive policies also play a key role. Key trends in the forecast period comprise improvements in biotechnology in relation to vaccine development, unexplored opportunities in the vaccine field, use of CRISPR and AI for cutting-edge solutions, fostering partnerships among pharmaceutical giants, and incorporation of telemedicine services.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21137&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Chikungunya Market?
The escalating occurrence of diseases transmitted by mosquitoes is predicted to significantly boost chikungunya market growth. Human infection with mosquito-borne diseases such as chikungunya, dengue, and zika virus happens via infected aedes mosquitoes and these diseases pose major global public health issues. Factors like climate change, urbanization, deforestation, accumulation of stagnant water, inadequate measures to control vectors, increased worldwide travel, and resistance to insecticides are contributing to the growing global incidence of these diseases. Chikungunya treatments aid patients by relieving symptoms like fever, joint pain, and inflammation, boosting overall comfort and mobility, reducing the likelihood of complications, and promoting recovery with hydration, pain management, and supportive care. For example, the UK Health Security Agency reported that from January to June 2024, dengue cases among returning travelers in England, Wales, and Northern Ireland increased by 201% to 473, compared to 157 cases during the same period in 2023. Hence, the rising global occurrence of mosquito-borne diseases is propelling chikungunya market expansion.
Which Key Market Segments Comprise the Chikungunya Market and Drive Its Revenue Growth?
The chikungunya market covered in this report is segmented –
1) By Type: Antiviral Drugs, Herbal And Complementary Treatments, Supportive Care, Vaccines
2) By Product Form: Liquid Form, Powder, Solid Form
3) By Disease Stage: Acute, Chronic, Post-Infection
4) By Sales Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Supermarkets
5) By End User: Caregivers, Healthcare Professionals, Patients
Subsegments:
1) By Antiviral Drugs: Nucleoside Analogues, Protease Inhibitors
2) By Herbal And Complementary Treatments: Ayurvedic Remedies, Homeopathic Treatments, Traditional Chinese Medicine
3) By Supportive Care: Pain Relievers (NSAIDs, Acetaminophen), Fluid Therapy, Physiotherapy
4) By Vaccines: Live-Attenuated Vaccines, Inactivated Vaccines, mRNA-Based Vaccines
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21137&type=smp
Which Areas Are Leading Regions in the Chikungunya Market Expansion Across the Globe?
North America was the largest region in the chikungunya market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chikungunya market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in theChikungunya Market Over the Coming Years?
Leading businesses in the chikungunya market are striving to produce innovative vaccines that enhance immunity, prevent epidemics, and respond to the increasing global health risk posed by chikungunya virus infections. A live attenuated chikungunya vaccine is such an example, which uses a mild version of the chikungunya virus to invoke an immune response without causing the disease and offers prolonged protection. In November 2023, an example of this was revealed when Valneva SE, a biotechnology firm based in France, announced the approval of IXCHIQ, a live attenuated chikungunya vaccine by the FDA, an agency affiliated with the US government. This approval was granted under the fast-track approval based on anti-CHIKV neutralizing antibody titers, with continued approval subject to verification of clinical benefit in additional studies. Additionally, Valneva obtained a Priority Review Voucher (PRV) from the FDA, which the company plans to capitalize on to fund its research and development projects. Administered as a single-dose muscle injection, Ixchiq comprises a live, weakened form of the chikungunya virus, which can cause symptoms similar to those of the chikungunya disease in recipients.
View the full report here:
https://www.thebusinessresearchcompany.com/report/chikungunya-global-market-report
How Is the Chikungunya Market Conceptually Defined?
Chikungunya (CHIKV) is a viral infection caused by the chikungunya virus, primarily transmitted to humans through the bites of infected Aedes aegypti and Aedes albopictus mosquitoes. The virus causes fever, joint pain, headache, rash, and muscle pain, significantly impacting the quality of life of affected individuals.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21137
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model